US PREMARKET MOVERS: SNDK, WDC, DDOG, HUBS, CEG, HONA, GOOGL, MRNA, DASH, LZ
ES +0.1% NQ -0.6% RTY unch
- SNDK -9.8%: Q1 guidance disappointed
- WDC -15%: Outlook underwhelmed
- DDOG -15.3%: Earnings missed lofty expectations
- HUBS -23.4%: Weak sales trends and reduced growth visibility weigh
- CEG +5.1%: Adj. EPS & rev. beat
- HONA -17.9%: Earnings and revenue missed expectations
- GOOGL -0.5%: Filed to sell US-denominated bonds in 10 tranches
- MRNA +3.6%: Moderna’s mRNA flu vaccine mFlusiva received US approval for adults aged 50 and over
- DASH +3.5%: Rev. beat
- LZ -27.2%: Rev. guide missed
A premarket sheet dominated by single-name earnings reactions rather than a macro driver, with the index futures nearly flat while individual software and storage names move double digits. The pattern is a familiar one at this stage of the reporting season: dispersion concentrated in high-multiple software and AI-adjacent hardware, where guidance has mattered more than the trailing print, and where names priced for flawless execution have been sold hard on anything short of a raise. The storage pair moving together on disappointing outlooks reads as a read-across within the peer set rather than purely idiosyncratic, a sequence that has tended to pull the whole sub-group before the market distinguishes between them. The bond filing from a mega-cap is a financing headline, not an equity story; large multi-tranche issuance from this issuer class has historically been absorbed without much fuss, though the size and timing against the rates calendar is the tell. On the positive side, a regulatory approval for a vaccine maker and a revenue beat in consumer internet are stock-specific and have tended not to travel beyond the name. What follows the open is whether the software selling broadens into the group or stays confined to the missers, and whether the desk sees any common thread in the guidance language around demand or spending cycles.